HEXACATH is a medical device company leader in Bio Active coronary Stent to treat Acute Coronary Syndromes.
| Website | http://www.hexacath.com |
| Revenue | $21.4 million |
| Employees | 47 (18 on RocketReach) |
| Founded | 1993 |
| Address | 4 Passage Saint-antoine, Rueil-Malmaison, Wallis and Futuna 92500, FR |
| Phone | +33 1 41 39 01 92 |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Biomaterials, Cardiology, Interventional Cardiology, Percutaneous Coronary Intervention, Pci, Bioscience, Angioplasty, Stent Technology, Medical Technology, Pharmaceutical |
| Competitors | Abbott, Stryker, Philips, Cardinal Health, Boston Scientific, BIOTRONIK, AngioDynamics, Terumo, Medtronic, Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] +39 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Hexacath employee's phone or email?
The Hexacath annual revenue was $21.4 million in 2026.
Anthony Brandy is the Directeur R and D et Industrialisation of Hexacath.
18 people are employed at Hexacath.
Hexacath is based in Rueil-Malmaison, Wallis and Futuna.
The NAICS codes for Hexacath are [33, 339].
The SIC codes for Hexacath are [38, 384].